Journal Home
Search for

Volume 87, Issue 2, Pages 184-191 (February 2010)


View previous. 9 of 27 View next.

Involvement of the cholinergic pathway in glucocorticoid-induced hyperinsulinemia in rats

Nágela Angelinia, Alex Rafachob, Antonio Carlos Boscheroa, José Roberto BosqueirobCorresponding Author Informationemail address

Received 13 July 2009; received in revised form 6 November 2009; accepted 9 November 2009. published online 07 December 2009.

Abstract 

Aims

We investigated the contribution of the cholinergic nervous system to dexamethasone-induced insulin resistance and hyperinsulinemia in rats.

Methods

Seventy-day-old Wistar male rats were distributed in groups: control (CTL), vagotomized (VAG), and sham operated (SHAM). On the 90th day of life, half of the rats were treated daily with 1mg/kg of dexamethasone for 5 days (CTL DEX, VAG DEX, and SHAM DEX).

Results

In the presence of 8.3mM glucose plus 100μM carbachol (Cch), isolated islets from CTL DEX secreted significantly more insulin than CTL. Cch-enhancement of secretion was further increased in islets from VAG CTL and VAG DEX than SHAM CTL and SHAM DEX, respectively. In CTL DEX islets, M3R and PLCβ1 and phosphorylated PKCα, but not PKCα, protein content was significantly higher compared with each respective control. In islets from VAG DEX, the expression of M3R protein increased significantly compared to VAG CTL and SHAM DEX. Vagotomy per se did not affect insulin resistance, but attenuated fasted and fed insulinemia in VAG DEX, compared with SHAM DEX rats.

Conclusion

These data indicate an important participation of the cholinergic nervous system through muscaric receptors in dexamethasone-induced hyperinsulinemia in rats.

a Department of Anatomy, Cellular Biology and Physiology, Institute of Biology, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil

b Department of Physical Education, School of Sciences, UNESP – Univ Estadual Paulista, Bauru, São Paulo, Brazil

Corresponding Author InformationCorresponding author. Tel.: +55 14 3103 6041; fax: +55 14 3103 6041.

PII: S0168-8227(09)00479-3

doi:10.1016/j.diabres.2009.11.008


View previous. 9 of 27 View next.